Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Orchid Pharma

BSE: 524372|NSE: ORCHIDPHAR|ISIN: INE191A01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 26, 16:00
30.35
0.5 (1.68%)
VOLUME 130,865
LIVE
NSE
May 26, 15:56
30.20
0.2 (0.67%)
VOLUME 291,961
Announcements on Orchid Pharma

26th-May-2017 18:17Source: BSE

Orchid Pharma- Press Release

Press Release in connection with Audited Financial Results for the year ended March 31, 2017

26th-May-2017 16:33Source: NSE

Orchid Pharma Limited

Orchid Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on May 26, 2017.

26th-May-2017 16:17Source: BSE

Orchid Pharma- Outcome of Board Meeting

Audited Financial Results for the quarter and year ended March 31, 2017

24th-May-2017 13:23Source: NSE

Orchid Pharma Limited

Orchid Pharma Limited has informed the Exchange that Orchid has received ANDA approval from US FDA for Aripiprazole Tablets USP, 2 mg , 5Mg, 10mg, 20mg, and 30mg on May 24, 2017.

24th-May-2017 13:08Source: BSE

Orchid Pharma- Updates

ANDA APPROVAL FROM USFDA FOR ARIPIPRAZOLE TABLET

17th-May-2017 17:08Source: BSE

Orchid Pharma- Board Meeting Intimation - May 26,2017- For Approval Of Audited Financial Results For The Year April 01,2016 To March 31,2017 And Trading Window Closure

Board meeting intimation - May 26,2017- For approval of Audited financial results for the year April 01,2016 to March 31,2017 and trading window closure

25th-Apr-2017 18:06Source: BSE

Orchid Pharma- Compliance Certificate For The Half Yearly Ended March 31, 2017

Certificate under Regulation 7(3) of the SEBI (LODR) Regulations, 2015

25th-Apr-2017 17:58Source: BSE

Orchid Pharma- Compliance Certificate By Practising Company Secretary Under Regulation 40(9) Of SEBI(LODR) Regulations, 2015

Certificate under Reg 40(9) of SEBI(LODR) Regulations, 2015 for the half yearly ended March 31, 2017

20th-Apr-2017 18:36Source: BSE

Orchid Pharma- Statement Of Investor Complaints For The Quarter Ended March 31, 2017

Statement of Investor Complaints during the three months from January 01, 2017 to March 31, 2017, pursuant to Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations...

19th-Apr-2017 18:00Source: BSE

Orchid Pharma- Shareholding for the Period Ended March 31, 2017

Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly

Board Meeting (Orchid Pharma)

Meeting Date

Remark

2017-05-26

Audited Results

Quick Links for Orchid Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.